Precision Medicine World Conference 2023 Silicon Valley

January 12, 2023

Haystack’s co-founder and Chief Innovation Officer, Josh Cohen, will be participating in a panel discussion at the upcoming Precision Medicine World Conference (PMWC) in Silicon Valey, CA. The panel, “Liquid Biopsy for Minimal Residual Disease,” will take place on January 26 and will bring together recognized leaders in the MRD field. With over 2,500 attendees from around the world, PMWC is the foremost precision medicine conference, promoting collaboration and knowledge-sharing among top global researchers, medical professionals, and biotech.

Learn more

Josh Cohen, Co-founder and Chief Innovation Officer

PMWC panel discussion

Title: Liquid Biopsy for Minimal Residual Disease
Track: 4
Date: January 26, 2023
Time: 3:30pm – 4:15pm Pacific
Location: Santa Clara, CA

Subscribe for updates

No spam, notifications only about new products, updates.

News and events

Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy

July 18, 2024

Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company and developer of best-in-class personalized MRD technology (Haystack MRD™), has entered a research collaboration with TriSalus Life Sciences to evaluate therapeutic response and provide molecular insights in connection with the clinical development

Haystack technology in action at ASCO 2024!

June 18, 2024

Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, has entered into a collaboration with Alliance Foundation Trials, LLC (AFT) for research use of Haystack Oncology’s personalized MRD technology (Haystack MRD™) to analyze therapeutic response and provide molecular insights for AFT’s

More news and events

Follow us on social media

Purpose-built, high-precision MRD testing

Connect with us

Your Privacy Choices

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.